China Biopharmaceuticals Holdings, Inc.
China Biopharmaceuticals Holdings, Inc., a prominent player in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across various regions. Founded in the early 2000s, the company has achieved significant milestones, establishing itself as a leader in the development and production of innovative biopharmaceutical products. Specialising in the research, manufacturing, and distribution of therapeutic drugs, China Biopharmaceuticals focuses on areas such as oncology, infectious diseases, and autoimmune disorders. Its unique portfolio includes monoclonal antibodies and recombinant proteins, which are designed to address unmet medical needs. With a strong market position, China Biopharmaceuticals Holdings has garnered recognition for its commitment to quality and innovation, contributing to advancements in healthcare both domestically and internationally. The company continues to expand its influence, striving to improve patient outcomes through cutting-edge biopharmaceutical solutions.
DitchCarbon Score
How does China Biopharmaceuticals Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China Biopharmaceuticals Holdings, Inc.'s score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China Biopharmaceuticals Holdings, Inc.'s reported carbon emissions
China Biopharmaceuticals Holdings, Inc. currently does not have available carbon emissions data, as no specific emissions figures have been reported. Consequently, there are no defined reduction targets or climate commitments outlined by the company. In the absence of concrete data, it is essential to note that the biopharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies in this sector are often encouraged to adopt science-based targets and engage in initiatives aimed at minimising their environmental impact. As such, China Biopharmaceuticals Holdings, Inc. may be expected to align with industry standards in the future, although specific commitments or targets have not been disclosed at this time.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Biopharmaceuticals Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
